Toceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ.
别名
SU 11654;PHA 291639;SU11654;SU-11654;PHA-291639;PHA291639;(Z)-5-(5-氟-2-氧代-2,3-二氢-1H-吲哚-3-亚基甲基)-2,4-二甲基-N-[2-(1-吡咯烷基)乙基]-1H-吡咯-3-甲酰胺;SU 11654;PHA 291639;SU11654;SU-11654;PHA-291639;PHA291639; 5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide